Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H LUND

Showing results (491-500 of 826) with videos related to

Pageof 83
Sort By:
European Journal of Heart Failure|July 7, 2023
Real-world use of sodium-glucose cotransporter 2 inhibitors in patients with heart failure and reduced ejection fraction: Data from the Swedish Heart Failure RegistryDavide Stolfo, Lars H Lund, Lina Benson, et al.
Therapeutic Advances in Gastroenterology|June 7, 2018
Proton-pump inhibitors among adults: a nationwide drug-utilization studyÓskar Ö Hálfdánarson, Anton Pottegård, Einar S Björnsson, et al.
Journal of Cardiac Failure|August 27, 2023
Does Heterogeneity Exist in Treatment Associations With Renin-Angiotensin-System Inhibitors or Beta-blockers According to Phenotype Clusters in Heart Failure with Preserved Ejection Fraction?Alicia Uijl, Stefan Koudstaal, Davide Stolfo, et al.
Journal of Cardiac Failure|April 23, 2026
Heart Failure With Mildly Reduced Ejection Fraction: A Heart Failure Society of America Scientific StatementJane E Wilcox, Lars H Lund, Zachary L Cox, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 26, 2016
Dialysis modality and nutritional status are associated with variability of inflammatory markersSunna Snaedal, Abdul R Qureshi, Sigrún H Lund, et al.
European Journal of Heart Failure|April 23, 2022
Transient versus persistent improved ejection fraction in non-ischaemic dilated cardiomyopathyPaolo Manca, Davide Stolfo, Marco Merlo, et al.
British Journal of Cancer|July 17, 1999
Granisetron compared with prednisolone plus metopimazine as anti-emetic prophylaxis during multiple cycles of moderately emetogenic chemotherapyT Sigsgaard, J Herrstedt, L J Andersen, et al.
Blood Advances|January 4, 2018
The impact of prior malignancies on second malignancies and survival in MM patients: a population-based studyGudbjörg Jonsdottir, Sigrún H Lund, Magnus Björkholm, et al.
Journal of Clinical Gastroenterology|May 10, 2016
Study of Gender Differences in Proton Pump Inhibitor Dose Requirements for GERD: A Double-Blind Randomized TrialHólmfridur Helgadóttir, David C Metz, Sigrún H Lund, et al.
Plos One|May 26, 2012
MicroRNA 10a marks regulatory T cellsLukas T Jeker, Xuyu Zhou, Kseniya Gershberg, et al.
Pageof 83

Showing results (491-500 of 826) with videos related to

Sort By:
Pageof 83
European Journal of Heart Failure|July 7, 2023
Real-world use of sodium-glucose cotransporter 2 inhibitors in patients with heart failure and reduced ejection fraction: Data from the Swedish Heart Failure RegistryDavide Stolfo, Lars H Lund, Lina Benson, et al.
Therapeutic Advances in Gastroenterology|June 7, 2018
Proton-pump inhibitors among adults: a nationwide drug-utilization studyÓskar Ö Hálfdánarson, Anton Pottegård, Einar S Björnsson, et al.
Journal of Cardiac Failure|August 27, 2023
Does Heterogeneity Exist in Treatment Associations With Renin-Angiotensin-System Inhibitors or Beta-blockers According to Phenotype Clusters in Heart Failure with Preserved Ejection Fraction?Alicia Uijl, Stefan Koudstaal, Davide Stolfo, et al.
Journal of Cardiac Failure|April 23, 2026
Heart Failure With Mildly Reduced Ejection Fraction: A Heart Failure Society of America Scientific StatementJane E Wilcox, Lars H Lund, Zachary L Cox, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 26, 2016
Dialysis modality and nutritional status are associated with variability of inflammatory markersSunna Snaedal, Abdul R Qureshi, Sigrún H Lund, et al.
European Journal of Heart Failure|April 23, 2022
Transient versus persistent improved ejection fraction in non-ischaemic dilated cardiomyopathyPaolo Manca, Davide Stolfo, Marco Merlo, et al.
British Journal of Cancer|July 17, 1999
Granisetron compared with prednisolone plus metopimazine as anti-emetic prophylaxis during multiple cycles of moderately emetogenic chemotherapyT Sigsgaard, J Herrstedt, L J Andersen, et al.
Blood Advances|January 4, 2018
The impact of prior malignancies on second malignancies and survival in MM patients: a population-based studyGudbjörg Jonsdottir, Sigrún H Lund, Magnus Björkholm, et al.
Journal of Clinical Gastroenterology|May 10, 2016
Study of Gender Differences in Proton Pump Inhibitor Dose Requirements for GERD: A Double-Blind Randomized TrialHólmfridur Helgadóttir, David C Metz, Sigrún H Lund, et al.
Plos One|May 26, 2012
MicroRNA 10a marks regulatory T cellsLukas T Jeker, Xuyu Zhou, Kseniya Gershberg, et al.
Pageof 83